CLINICAL_TRIALS
trial_result
· 2021-11-18
Clinical Trial Update: Early Intervention in COVID-19: Favipiravir Verses Standard Care [Phase 3]
Summary
Phase 3 trial comparing favipiravir to standard care for coronavirus infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chelsea and Westminster NHS Foundation Trust | Conditions: Coronavirus Infection | Phase 3 | Status: COMPLETED